News & Updates
Filter by Specialty:
Booster COVID-19 vacc cuts breakthrough infection risk, particularly in individuals with no immune dysfunction
Receipt of a booster dose of the COVID-19 vaccine reduces the risk of breakthrough COVID-19 infections* compared to full vaccination only, particularly among individuals without immunosuppressed/compromised conditions (ISC), according to a US study presented at CROI 2022.
Booster COVID-19 vacc cuts breakthrough infection risk, particularly in individuals with no immune dysfunction
17 Mar 2022
Corticosteroids help prevent hearing loss, neurologic sequelae in paediatric bacterial meningitis
Children with bacterial meningitis appear to fare well with corticosteroids, which lead to a lower incidence of hearing loss and neurologic sequelae and faster resolution of fever, according to a meta-analysis.
Corticosteroids help prevent hearing loss, neurologic sequelae in paediatric bacterial meningitis
15 Mar 2022
Sofosbuvir easy on the kidneys
Use of sofosbuvir-based direct-acting antiviral regimens for treating hepatitis C virus (HCV) in clinical trial participants with chronic kidney disease (CKD) does not appear to worsen estimated glomerular filtration rate levels, according to a study. Furthermore, the drug does not appear to contribute to an increased risk of end-stage renal disease among HCV patients with CKD treated in clinical practice.
Sofosbuvir easy on the kidneys
15 Mar 2022
People who trust formal information source more likely to get COVID-19 jab
Among middle-aged and older adults, trust in formal sources of vaccine information, such as government agencies, is a strong predictor of willingness to get vaccinated against the coronavirus disease 2019 (COVID-19), according to a recent Singapore study.